← Back to graph
Prescription

tirzepatide compounded with B12

Selected indexed studies

  • A novel, widespread impurity in mass-compounded tirzepatide/B12 products: potential patient safety implications. (Expert Opin Drug Saf, 2026) [PMID:42010938]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Sources

Local graph